Blueprint Medicines Corp logo

Blueprint Medicines Corp

FRA:2L9 (USA)  
€ 95.70 (+0.69%) May 23
At Loss
P/B:
20.69
Market Cap:
€ 5.92B ($ 6.40B)
Enterprise V:
€ 5.63B ($ 6.08B)
Volume:
1.00K
Avg Vol (2M):
130.00
Also Trade In:

Blueprint Medicines Corp Operating Data

Blueprint Medicines Corp Competitors' Latest Operating Data

Operating data not available.

Blueprint Medicines Corp (FRA:2L9) Operating Data Charts